Structure (Image 01)
Tranexamic Acid Tablet
Product Images NDC 62559-265
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 62559-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
This text provides data on Mean Menstrual Blood Loss (mL) for different treatment periods and cycles, including Tranexamic Aqd Tablets and Placebo for a study. The data is presented in a table with baseline and cycle information.*
Label (Image 03)
NDC 62559-265-30 is a prescription-only medication consisting of Tranexamic Acid tablets that contain 650 mg. The medication is used as per the directions mentioned on the package insert. The medication should be stored between 68° to 77°F and should be kept out of the reach of children. The medication is produced by Suzhou Amerigen Pharmaceutical Co. Ltd in Jiangsu, China, and distributed by ANI Pharmaceuticals, Inc in Baudette, MN, with a GTIN of 00362559000000. The expiration date and manufacturing LOT number are printed on the packaging for reference.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
